A within‐subject comparison of neuromelanin MRI and DAT SPECT (with [123I]FP‐β‐CIT) showed that neuromelanin MRI could predict motor complications such as LIDs in PD patients, while DAT SPECT could not (Okuzumi et al., 2019). Here, SLC6A3 is linked to Parkinson disease.